Literature DB >> 291993

Apolipoproteins in human cerebrospinal fluid.

P S Roheim, M Carey, T Forte, G L Vega.   

Abstract

The presence of apolipoproteins A-I, E, C-II, and C-III and the absence of apolipoprotein B was demonstrated in human cerebrospinal fluid. The concentration of apolipoproteins was measured by electroimmunoassay. Apolipoproteins E, C-II, and C-III were present in cerebrospinal fluid at 3--5% of their concentration in plasma; the cerebrospinal fluid level of apolipoprotein A-I was 0.4%. Most of the cerebrospinal fluid apolipoproteins were present in the rho less than 1.21 g/ml lipoprotein fraction. The major apolipoporteins of cerebrospinal fluid are E and A-I. The possible mechanism of transfer and the physiological and pathophysiological role of apolipoproteins in cerebrospinal fluid are postulated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 291993      PMCID: PMC411636          DOI: 10.1073/pnas.76.9.4646

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  THE FORMATION OF PLASMA LIPOPROTEINS FROM APOPROTEIN IN PLASMA.

Authors:  P S ROHEIM; L MILLER; H A EDER
Journal:  J Biol Chem       Date:  1965-07       Impact factor: 5.157

2.  [Immunoelectrophoretic method for the analysis of mixtures of antigenic substances].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1955-05

3.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

4.  Interaction of plasma high density lipoprotein HDL2b (d 1.063-1.100 g/ml) with single-bilayer liposomes of dimyristoylphosphatidylcholine.

Authors:  A V Nichols; E L Gong; T M Forte; P J Blanche
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

Review 5.  Lipoprotein apoprotein metabolism.

Authors:  E J Schaefer; S Eisenberg; R I Levy
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

Review 6.  The low-density lipoprotein pathway and its relation to atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 8.  The plasma lipoproteins.

Authors:  J C Osborne; H B Brewer
Journal:  Adv Protein Chem       Date:  1977

9.  Cholesterol ester hydrolase activity in human cerebrospinal fluid.

Authors:  S N Shah; R C Johnson
Journal:  Exp Neurol       Date:  1978-01-01       Impact factor: 5.330

10.  Isolation and characterization of a human serum cholesteryl ester transfer protein.

Authors:  T Chajek; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

View more
  72 in total

1.  Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

Authors:  M D Neely; L L Swift; T J Montine
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

2.  Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.

Authors:  C Hesse; H Larsson; P Fredman; L Minthon; N Andreasen; P Davidsson; K Blennow
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

3.  Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Authors:  C N Bassett; M D Neely; K R Sidell; W R Markesbery; L L Swift; T J Montine
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

4.  ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Authors:  Anne M Fagan; Erin Christopher; Jennie W Taylor; Maia Parsadanian; Michael Spinner; Melanie Watson; John D Fryer; Suzanne Wahrle; Kelly R Bales; Steven M Paul; David M Holtzman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 5.  HDL-cholesterol and apolipoproteins in relation to dementia.

Authors:  Manja Koch; Majken K Jensen
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

6.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

7.  CSF Apo-E levels associate with cognitive decline and MRI changes.

Authors:  Jon B Toledo; Xiao Da; Michael W Weiner; David A Wolk; Sharon X Xie; Steven E Arnold; Christos Davatzikos; Leslie M Shaw; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-01-03       Impact factor: 17.088

8.  Microsequencing of bovine cerebrospinal fluid apolipoproteins: identification of bovine apolipoprotein E.

Authors:  D L Puppione; W H Fischer; M Park; O S Gazal; G L Williams
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

9.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

10.  Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells.

Authors:  Toshiyuki Nakamura; Atsushi Watanabe; Takahiro Fujino; Takashi Hosono; Makoto Michikawa
Journal:  Mol Neurodegener       Date:  2009-08-20       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.